Arzneimittelforschung 2010; 60(11): 654-659
DOI: 10.1055/s-0031-1296343
CNS-active Drugs · Hypnotics · Psychotropics · Sedatives
Editio Cantor Verlag Aulendorf (Germany)

Quantification of quetiapine in human plasma by reverse phase high performance liquid chromatography

Dev Prakash
1   Bioanalytical wing, Manipal AcuNova KH Clinical Research Center, Manipal, Karnataka, India
,
Krishnamurthy Bhat
2   Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India
,
Raghavendra Shetty
1   Bioanalytical wing, Manipal AcuNova KH Clinical Research Center, Manipal, Karnataka, India
,
Parveen Chaudhary
2   Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India
,
Sri Ram Pathak
2   Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal, Karnataka, India
,
Ghosh Amitabha
1   Bioanalytical wing, Manipal AcuNova KH Clinical Research Center, Manipal, Karnataka, India
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
30. Dezember 2011 (online)

Abstract

The objective of the present investigation is to develop and validate a simple, economical and reliable high performance liquid chromatography method for the quantification of quetiapine (CAS 111974-72-2) in human plasma with a quantification limit sufficiently low to support pharmacokinetic studies. Imipramine hydrochloride (CAS 113-52-0) was used as internal standard. The validated method allows quantification of quetiapine in 15–1000 ng/mL. The method was shown to be precise (≤ 7% coefficient of variation, CV) and accurate (≤ 10% relative error, RE). The correlation coefficient for quetiapine was > 0.9970. The simplicity of the assay and rapid liquid-liquid extraction make it an attractive procedure in high-throughput bioanalysis of quetiapine.

 
  • References

  • 1 Maryadele JO. The Merck Index. Whitehouse Station (NJ):: Merck and Co.; 2001
  • 2 Buckley P. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials. Curr Med Res Opin. 2004; 20 (9) 1357-63
  • 3 Siegfried K, Johannes T, Heiden A. Quetiapine efficacy and tolerability in schizophrenia. Eur Neuropsychopharmacol. 2001; 11: S405-13
  • 4 Goldstein JM. Mechanism of action of quetiapine: a modulator of dopamine at the D2 receptor. Schizophr Res. 2003; 60: 311
  • 5 Arvanitis LA. Clinical profile of seroquel (quetiapine). In: Holliday SC, Ancill RJ, MacEwan GW, editors. phrenia:he barriers. New York (NY):: John Wiley & Sons; 1996: 209-236
  • 6 Davis PC, Wong J, Gefvert O. Analysis and pharmacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection. J Pharm Biomed Anal. 1999; 20 (1–2) 271-82
  • 7 Barrett B, Holcapek M, Huclová J, Borek-Dohalský V, Ne-mec B, Jelínek I et al. Validated HPLC-MS/MS method for determination of quetiapine in human plasma. J Pharm Biomed Anal. 2007; 44 (2) 498-505
  • 8 Zhou Z, Li X, Xie Z, Cheng Z, Peng W, Wang F et al. Simultaneous determination of clozapine, olanzapine, risperidone and quetiapine in plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 802 (2) 257-62
  • 9 Mandrioli R, Fanali S, Ferranti A, Raggi MA. HPLC analysis of the novel antipsychotic drug quetiapine in human plasma. J Pharm Biomed Anal. 2002; 30 (4) 969-77
  • 10 Pullen RH, Palermo KM, Curtis MA. Determination of an antipsychotic agent (ICI 204,636) and its 7-hydroxy metabolite in human plasma by high-performance liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr B Biomed Appl. 1992; 573 (1) 49-57
  • 11 Sachse J, Köller J, Härtter S, Hiemke C. Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performance-liquid chromatography with column-switching and spectrophotometric detection. J Chromatogr B. 2006; 830 (2) 342-48
  • 12 Tu JY, Xu P, Dan-Hua Xu DH, Li HD. UPLC–MS–MS Analysis of quetiapine and its two active metabolites, 7-hydroxy-quetiapine and 7-hydroxy-n-dealkylquetiapine, in rat plasma and cerebrospinal fluid. Chromatographia. 2008; 68 (7–8) 525-32
  • 13 Pucci V, Mandrioli R, Ferranti A, Furlanetto S, Raggi MA. Quality control of commercial tablets containing the novel antipsychotic quetiapine. J Pharm Biomed Anal. 2003; 32 (4–5) 1037-44
  • 14 Li KY, Cheng ZN, Li X, Bai XL, Zhang BK, Wang F et al. Simultaneous determination of quetiapine and three metabolites in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry. Acta Pharmacol Sin. 2004; 25 (l) 110-4
  • 15 Fathalla B, Amina E, Manal E, Jenny J. Stability-indicating hplc method for the determination of quetiapine: application to tablets and human plasma. J Liq Chromatogr Relat Technol. 2008; 31 (9) 1283-98
  • 16 Nirogi R, Bhyrapuneni G, Kandikere V, Mudigonda K, Ajjala D, Mukkanti K. Sensitive liquid chromatography tandem mass spectrometry method for the quantification of quetiapine in plasma. Biomed Chromatogr. 2008; 22 (10) 1043-55
  • 17 Saracino MA, Mercolini L, Flotta G, Albers LJ, Merli R, Raggi MA. Simultaneous determination of fluvoxamine isomers and quetiapine in human plasma by means of high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 843 (2) 227-33
  • 18 Wen Y, Zhang M, Liao R, Zeng Z. Rapid determination of plasma concentration of quetiapine by HPLC-ESI-MS/MS. Zhongguo Yaofang Zazhishe. 2007; 18 (32) 2504-6
  • 19 Mercolini L, Grillo M, Bartoletti C, Boncompagni G, Raggi MA. Simultaneous analysis of classical neuroleptics, atypical antipsychotics and their metabolites in human plasma. Springer Anal Bioanal Chem. 2007; 388 (l) 235-43